Tag: Monoclonal antibody
News
After record low global pharma companies’ return on R&D investment increases
The world’s top 20 pharmaceutical companies collectively spent $145 billion on their research and development (R&D) investments in 2022-23, up from $139 billion in...
Cell and Gene Therapy Catapult welcomes new non-executive directors
The Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy...
Locate Bio raises £9.2m to progress LDGraft clinical study for anterior lumbar interbody fusion
Locate Bio, an orthobiologics company, has successfully completed an oversubscribed £9.2 million funding round from both new investors and existing investors, Mercia Ventures and...
